Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Calidi Biotherapeutics announced it will present new data on its RedTail platform at the ASGCT annual meeting. The platform enables systemic delivery of virotherapy targeting tumors and remodeling the tumor microenvironment, with the lead candidate CLD-401 expected to file an IND by the end of 2026. The data demonstrates the platform's ability to d…